Description
Tirzepatide is a synthetic peptide research compound acting as a dual agonist at the GIP and GLP-1 receptors. Researchers study it as a probe of combined incretin signaling.
In cultured cells and laboratory animals, investigations have focused on glucose balance, insulin secretion, appetite-related testing, and simultaneous activation of two incretin receptors. Its co-agonist design supports research into how the two receptors cooperate.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.
Reviews
There are no reviews yet.